Literature DB >> 2342809

Orbital decompression for Graves' ophthalmopathy by inferomedial, by inferomedial plus lateral, and by coronal approach.

M P Mourits1, L Koornneef, W M Wiersinga, M F Prummel, A Berghout, R van der Gaag.   

Abstract

To test the efficacy and safety of orbital decompression for Graves' ophthalmopathy, the authors studied the records of 60 consecutive patients who were operated on for dysthyroid optic neuropathy or for rehabilitative purposes. Patients decompressed for neuropathy were older, had less proptosis, and a shorter duration of eye disease than patients operated on for disfigurement. The authors compared the results of three surgical procedures including the inferomedial, the inferomedial plus lateral, and the coronal approach. Regarding improvement of visual function, no difference was found between the three techniques. Patients in whom vision failed to recover had a high prevalence of diabetes mellitus. Proptosis reduction varied from 1 to 9 mm, depending on the number of walls decompressed. There was no net change in the prevalence of diplopia. Persistent complications were seen in less than 5% of all decompressions. The authors conclude that orbital decompression for Graves' ophthalmopathy is safe and efficacious, regardless of surgical procedure. However, the coronal approach gives the best cosmetic results.

Entities:  

Mesh:

Year:  1990        PMID: 2342809     DOI: 10.1016/s0161-6420(90)32532-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  26 in total

1.  Diabetes mellitus: a risk factor in patients with Graves' orbitopathy.

Authors:  R Kalmann; M P Mourits
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

2.  Coronal approach for rehabilitative orbital decompression in Graves' ophthalmopathy.

Authors:  R Kalmann; M P Mourits; J P van der Pol; L Koornneef
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

Review 3.  [Endocrine orbit disorders. Pathogenesis, clinical presentation and examination, stage-dependent therapy].

Authors:  A Eckstein; J Esser
Journal:  Ophthalmologe       Date:  2003-10       Impact factor: 1.059

4.  Contrast sensitivity and the diagnosis dysthyroid optic neuropathy.

Authors:  M P Mourits; M S Suttorp-Schulten; R O Tijssen; P Apkarian
Journal:  Doc Ophthalmol       Date:  1990 Apr-Jul       Impact factor: 2.379

5.  Lid lengthening by sclera interposition for eyelid retraction in Graves' ophthalmopathy.

Authors:  M P Mourits; L Koornneef
Journal:  Br J Ophthalmol       Date:  1991-06       Impact factor: 4.638

Review 6.  Management of dysthyroid eye disease.

Authors:  P Fells
Journal:  Br J Ophthalmol       Date:  1991-04       Impact factor: 4.638

7.  [Surgical therapy in Graves' orbitopathy].

Authors:  J Kaminsky; G J Ridder; A Eckstein; M Metzger; F Beisse
Journal:  Ophthalmologe       Date:  2011-05       Impact factor: 1.059

8.  Effects of bilateral orbital decompression by an endoscopic endonasal approach in dysthyroid orbitopathy.

Authors:  A Neugebauer; K Nishino; P Neugebauer; W Konen; O Michel
Journal:  Br J Ophthalmol       Date:  1996-01       Impact factor: 4.638

9.  Retrobulbar pressures measured during surgical decompression of the orbit.

Authors:  A J Otto; L Koornneef; M P Mourits; L Deen-van Leeuwen
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638

10.  Update on thyroid eye disease and management.

Authors:  Erick D Bothun; Ryan A Scheurer; Andrew R Harrison; Michael S Lee
Journal:  Clin Ophthalmol       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.